Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

Identifieur interne : 000507 ( Main/Exploration ); précédent : 000506; suivant : 000508

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

Auteurs : Mark R. Cookson [États-Unis]

Source :

RBID : ISTEX:2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9

Abstract

Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene — leucine-rich repeat kinase 2 (LRRK2) — affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.

Url:
DOI: 10.1038/nrn2935


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</title>
<author>
<name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1038/nrn2935</idno>
<idno type="url">https://api.istex.fr/document/2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000218</idno>
<idno type="wicri:Area/Main/Curation">000180</idno>
<idno type="wicri:Area/Main/Exploration">000507</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</title>
<author>
<name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health (NIH), Building 35, Room 1A116, MSC 3707, 35 Convent Drive, Bethesda, 20982-3707</wicri:regionArea>
<wicri:noRegion>20982-3707</wicri:noRegion>
</affiliation>
<affiliation>
<wicri:noCountry code="no comma">E-mail: Cookson@mail.nih.gov</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Nature Reviews Neuroscience</title>
<idno type="ISSN">1471-003X</idno>
<idno type="eISSN">1471-0048</idno>
<imprint>
<publisher>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</publisher>
<date type="published" when="2010-12">2010-12</date>
<biblScope unit="volume">11</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="791">791</biblScope>
<biblScope unit="page" to="797">797</biblScope>
</imprint>
<idno type="ISSN">1471-003X</idno>
</series>
<idno type="istex">2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9</idno>
<idno type="DOI">10.1038/nrn2935</idno>
<idno type="ArticleID">nrn2935</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1471-003X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="eng">Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene — leucine-rich repeat kinase 2 (LRRK2) — affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Cookson, Mark R" sort="Cookson, Mark R" uniqKey="Cookson M" first="Mark R." last="Cookson">Mark R. Cookson</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000507 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000507 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:2A6E61C69AE50BC4A223D63F1A96E7BD0A5A40C9
   |texte=   The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024